Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir

Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir

Abstract Introduction Nirmatrelvir/ritonavir (NMV/r) is approved in the United States (US) and more than 70 other countries for the treatment of mild to moderate COVID-19 in nonhospitalized adults at high risk for severe disease. Because ritonavir inhibits several drug metabolizing enzymes, potentia...

Full description

Bibliographic Details
Main Authors: Victoria Hendrick, Erast Pohorylo, Lubna Merchant, Jackie Gerhart, Iqra Naz Arham, Florin Draica, Romina Quercia, Ayman Ayoub, Reema Mehta
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-10-01
Series:Infectious Diseases and Therapy
Subjects:
Interactions
Nirmatrelvir
Ritonavir
Online Access:https://doi.org/10.1007/s40121-024-01050-w

Internet

https://doi.org/10.1007/s40121-024-01050-w

Similar Items